Allergan Botox Limited
Records under this name other than patents Allergan Botox Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Allergan Botox Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,087,327 | Compositions and methods for chemodenervation using neurotoxins Formerly held Term ended Term ended Jan 30, 2018 · USPTO record | Term ended | Term ended Jan 30, 2018 | USPTO record |
| US 6,063,768 | Application of botulinum toxin to the management of neurogenic inflammatory disorders Formerly held Term ended Term ended Sep 4, 2017 · USPTO record | Term ended | Term ended Sep 4, 2017 | USPTO record |
| US 6,967,088 | Soluble recombinant botulinum toxin proteins Lapsed on the fee record Ended Nov 22, 2013 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2013 | USPTO record |